Association Between Interlukin 10 Gene Polymorphism And Susceptibility To Diabetic Kidney Disease

A Key Role of Interleukin 34 in Patients with Chronic Kidney Disease and Lupus Nephritis

Interleukin –18 and other inflammatory cytokines as independent predictors of diabetic nephropathy in patients with type 2 diabetes mellitus.

The pro-inflammatory cytokine Tumor Necrosis Factor alpha (TNF-α) in Diabetic Nephropathy

Relation Between Kidney Injury Molecule 1 (KIM 1) And Diabetic Nephropathy

Interleukin-18 as a Urinary Biomarker for Diagnosis of Hepatorenal Syndrome in Patients with Decompensated Liver Cirrhosis

Complement 3a and Complement 5a as Biochemical Markers in Diabetic Nephropathy

Role of Kidney Injury Molecule-1 and β2-Microglobulin in Early Diagnosis of Diabetic Nephropathy

Diagnostic performances of tumor necrosis factor-alpha and type IV collagen for diabetic nephropathy in type 2 diabetic patients

Tissue inhibitor metalloproteinase-1, Plasminogen activator inhibitor 1, and neutrophil/lymphocyte ratio as potential early biomarkers for diabetic nephropathy